Abstract:Background: The prevalence of diabetes mellitus remains high in China, and more cardiovascular and cerebrovascular adverse events due to diabetes mellitus are likely to occur in the future. Objective: To analyze the gap between the current pharmacotherapy management and the guidelines for inpatients with type 2 diabetes mellitus from the perspective of pharmacists so as to provide a reference for optimal pharmacotherapy management methods and models for patients with type 2 diabetes mellitus. Methods: The study was a cross-sectional observational study. The study was conducted by investigating and analyzing the use of glucose-lowering drugs, adjustment of blood pressure management strategy, lipid management, weight management, and application of antiplatelet drugs in type 2 diabetes inpatients. Results: A total of 1086 patients with type 2 diabetes were included. Metformin, glycosidase inhibitors, and basal insulin were the most used among type 2 diabetes inpatients. The use of SGLT-2, GLP-1 RAs, DPP-4, and metformin all showed significant increase. SGLT-2 inhibitors (SGLT-2i) showed the fastest increase from 2020 to 2021 (14.5% vs. 39.6%); However, the application rate of SGLT-2i was low among patients with combined ASCVD, renal insufficiency, and diabetic nephropathy (46.4%, 40.9%, and 45.8% respectively). For patients with substandard blood pressure at admission, the average rate of intervention by endocrinologists for adjusting the antihypertensive regimen during hospitalization was 55.6%, and the application rate of ACEI/ARB drugs reached 64.4%. The application rate of statins among patients with type 2 diabetes was still relatively high, at 78.8%. However, the overall intervention rate for patients with suboptimal LDL-c was only 24.1%. The application rate of antiplatelet agents for patients with ASCVD was 77.6%, which was higher than that for patients without ASCVD. Conclusion: There is still a gap between the practice of medication treatment management of Chinese inpatients with type 2 diabetes and the guidelines, especially in the application of GLP-1RAs and SGLT-2i in patients with concomitant ASCVD, diabetic nephropathy, and renal insufficiency. Meanwhile, physicians and pharmacists should pay more attention on achieving blood pressure and LDL-c standards in type 2 diabetic patients and provide timely interventions.

[Development and Interpretation of China Medical Nutrition Therapy Guideline for Diabetes (2010)].

Dietary Guidelines for Chinese Residents (2016): Comments and Comparisons

Relationship between Mechanism of GLP - 1 and Syndrome of Damp - Heat of Spleen and Stomach of Diabetes

International traditional Chinese medicine guideline for diagnostic and treatment principles of diabetes

Standards of medical care for type 2 diabetes in China 2019

Investigation into Knowledge, Attitude, and Practice on Medical Nutrition Therapy among Patients with Diabetes in China - Results from a national, multicenter cross-sectional study.

[National guidelines for the prevention and control of diabetes in primary care (2022)]

"Chinese Guideline for Type 2 Diabetes Mellitus" Comprises Chinese Characters

The Development of Malnutrition Assessment Criteria and the Analysis of Current Problems

The future of prevention and treatment of diabetes with nutrition in China

Guidelines for Parenteral and Enteral Nutrition Support in Geriatric Patients in China.

Diabetes nutrition therapy and dietary intake among individuals with Type 1 diabetes in China

Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China

Quality assessment of type 1 diabetes mellitus clinical practice guidelines

[The Progression of Parenteral and Enteral Nutrition Based on New Guidelines].

Evolution in the Chinese Diabetes Society Standards of Care for Type 2 Diabetes.

Treatment of diabetes using traditional Chinese medicine: past, present and future.

Following the Chinese Guideline of Diabetic Retinopathy in Our Practice

Gaps of Medication Treatment Management Between Guidelines and Real-World for Inpatients With Type 2 Diabetes in China From Pharmacist's Perspective

Developments in the study of Chinese herbal medicine's assessment index and action mechanism for diabetes mellitus

Dilemmas in Elderly Diabetes and Clinical Practice Involving Traditional Chinese Medicine